Učitavanje...
Losartan reduces cigarette smoke-induced airway inflammation and mucus hypersecretion
The aim was to determine whether losartan reduces cigarette smoke (CS)-induced airway inflammation and mucus hypersecretion in an in vitro model and a small clinical trial. Primary human bronchial epithelial cells (HBECs) were differentiated at the air–liquid interface (ALI) and exposed to CS. Expre...
Spremljeno u:
| Izdano u: | ERJ Open Res |
|---|---|
| Glavni autori: | , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
European Respiratory Society
2021
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7836504/ https://ncbi.nlm.nih.gov/pubmed/33532463 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/23120541.00394-2020 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|